EMEA-001082-PIP02-11-M03
Key facts
| Invented name |
Holoclar
|
| Active substance |
Ex vivo expanded autologous human corneal epithelium cells containing stem cells
|
| Therapeutic area |
Ophthalmology
|
| Decision number |
P/0066/2022
|
| PIP number |
EMEA-001082-PIP02-11-M03
|
| Pharmaceutical form(s) |
Living tissue equivalent
|
| Condition(s) / indication(s) |
Treatment of limbal stem cell deficiency due to ocular burns
|
| Route(s) of administration |
Ophthalmic use
|
| Contact for public enquiries |
Holostem Terapie Avanzate S.r.l.
+39 3492403930 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|